409 related articles for article (PubMed ID: 8780463)
1. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.
Ismail M; Metwally A; Farghaly A; Bruce J; Tao LF; Bennett JL
Am J Trop Med Hyg; 1996 Aug; 55(2):214-8. PubMed ID: 8780463
[TBL] [Abstract][Full Text] [Related]
2. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.
Ismail M; Botros S; Metwally A; William S; Farghally A; Tao LF; Day TA; Bennett JL
Am J Trop Med Hyg; 1999 Jun; 60(6):932-5. PubMed ID: 10403323
[TBL] [Abstract][Full Text] [Related]
3. A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
Radwan A; El-Lakkany NM; William S; El-Feky GS; Al-Shorbagy MY; Saleh S; Botros S
Parasit Vectors; 2019 Jun; 12(1):304. PubMed ID: 31208446
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
[TBL] [Abstract][Full Text] [Related]
5. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
Fallon PG; Doenhoff MJ
Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
[TBL] [Abstract][Full Text] [Related]
6. Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt.
Botros S; Sayed H; Amer N; El-Ghannam M; Bennett JL; Day TA
Int J Parasitol; 2005 Jun; 35(7):787-91. PubMed ID: 15925597
[TBL] [Abstract][Full Text] [Related]
7. Laboratory induced resistance to praziquantel in experimental schistosomiasis.
Ismail MM; Taha SA; Farghaly AM; el-Azony AS
J Egypt Soc Parasitol; 1994 Dec; 24(3):685-95. PubMed ID: 7844435
[TBL] [Abstract][Full Text] [Related]
8. Resistance of Schistosoma mansoni to praziquantel: is there a problem?
Doenhoff MJ; Kusel JR; Coles GC; Cioli D
Trans R Soc Trop Med Hyg; 2002; 96(5):465-9. PubMed ID: 12474468
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in mice.
Tanaka M; Ohmae H; Utsunomiya H; Nara T; Irie Y; Yasuraoka K
Am J Trop Med Hyg; 1989 Aug; 41(2):198-203. PubMed ID: 2505624
[TBL] [Abstract][Full Text] [Related]
10. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
Bonesso-Sabadini PI; de Souza Dias LC
Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
[TBL] [Abstract][Full Text] [Related]
11. Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.
El-Feky GS; Mohamed WS; Nasr HE; El-Lakkany NM; Seif El-Din SH; Botros SS
Antimicrob Agents Chemother; 2015; 59(6):3501-8. PubMed ID: 25845870
[TBL] [Abstract][Full Text] [Related]
12. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.
Sabra AN; Botros SS
J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
Barakat R; El Morshedy H
Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and bioavailability of different praziquantel brands.
Botros S; El-Lakkany N; Seif el-Din SH; Sabra AN; Ibrahim M
Exp Parasitol; 2011 Feb; 127(2):515-21. PubMed ID: 21044626
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the antioxidant defence in different developmental stages of Schistosoma mansoni by praziquantel and artemether.
El-Bassiouni EA; Helmy MH; Saad EI; El-Nabi Kamel MA; Abdel-Meguid E; Hussein HS
Br J Biomed Sci; 2007; 64(4):168-74. PubMed ID: 18236739
[TBL] [Abstract][Full Text] [Related]
16. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
17. Resistance to praziquantel, effect of drug pressure and stability test.
Ismail MM; Farghaly AM; Dyab AK; Afify HA; el-Shafei MA
J Egypt Soc Parasitol; 2002 Aug; 32(2):589-600. PubMed ID: 12214936
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni.
Mohammad OS; Hussein HM; Abdel-Sayed SW; Mohamed GA; Shehata MAS
Parasitol Res; 2024 May; 123(5):215. PubMed ID: 38771511
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of mefloquine and praziquantel combination therapy in mice harbouring juvenile and adult Schistosoma mansoni.
el-Lakkany NM; el-Din SH; Sabra AN; Hammam OA
Mem Inst Oswaldo Cruz; 2011 Nov; 106(7):814-22. PubMed ID: 22124553
[TBL] [Abstract][Full Text] [Related]
20. Antischistosomal effects of praziquantel, its alkaline hydrolysis and sun decomposed products on experimentally S. mansoni infected albino mice. (A) Efficacy assessment based on clinicopathological findings.
Suleiman MI; Akarim EI; Ibrahim KE; Saad AM; Mohammed AE; Ahmed BM; Sulaiman SM
J Egypt Soc Parasitol; 2004 Apr; 34(1):131-42. PubMed ID: 15143740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]